The lack of efficient in vivo gene delivery is a well-known shortcoming of nonviral delivery vectors, in particular of chemical vectors. We developed a series of novel nonviral carriers for plasmid-based in vivo gene delivery. This new transport device is based on the assembly of DNA plasmids with synthetic derivatives of naturally occurring moleculesfatty acid-spermine conjugates (or lipospermines). We tested the ability of these fatty acid conjugates to interact with plasmid DNA (pDNA) and found that they formed DNA nanocomplexes, which are protected from DNase I degradation. This protection was shown to directly correlate with the length of the aliphatic component. However, this increase in the length of the hydrocarbon chain resulted in increased toxicity. The cationic lipids used for transfection typically have a C 16 and C 18 hydrocarbon chain. Interestingly, toxicity studies, together with further characterization studies, suggested that the two most suitable candidates for in vivo delivery are those with the shortest hydrocarbon chain, butanoyl-and decanoylspermine. Morphological characterization of DNA nanocomplexes resulting from these lipospermines showed the formation of a homogenous population, with the diameter ranging approximately from 40 to 200 nm. Butanoylspermine was found to be the most promising carrier from this series, resulting in a significantly increased gene expression, in relation to naked plasmid, in both tissues herein targeted (dermis and M. tibialis anterior). Thus, we established a correlation between the in vitro properties of the ensuing DNA nanocarriers and their efficient in vivo gene expression.
Introduction
Nonviral gene delivery systems are well known not only for the biosafety they offer over viral carriers but also for the fact that their efficiency is much at the rear compared with that of the latter. Physical methods have been shown to be highly efficient in targeting several tissues, especially skeletal muscle or cancer tissues. [1] [2] [3] [4] Yet, all the electrical equipments used in this method present some inconveniences. Chemical vectors are, therefore, an alternative and are the focus of this work. Compared with physical methods, chemical systems have low efficiency and, in spite of their safety, they frequently show toxic properties because of the high concentrations of carriers that are needed to obtain significant gene expression. [5] [6] [7] [8] Thus, highly efficient nonviral gene carriers are needed. For this purpose, DNA condensation is a recurrent requisite for this type of nonviral therapeutic approach. 5, [8] [9] [10] [11] [12] Bloomfield 13 has defined DNA condensation as the collapse of extended DNA chains into compact, orderly particles containing only one or a few molecules. Typically, this process results from a neutralization of the negative charges of the DNA phosphate groups with transition into the ordered phase that occurs when 90% of charges are neutralized. 13 Different systems have been proposed and tested for nonviral gene delivery based on DNA condensation and protection. 12, 14, 15 However, the drawback of this therapeutic approach is often the lack of a successful in vivo application. There is clearly a need to develop highly efficient, chemical, nonviral gene carriers that can protect DNA and persist under physiological in vivo conditions.
Taking this into consideration, polyamines would seem excellent candidates as one of the roles of these naturally occurring molecules is related to DNA condensation. 16 Nevertheless, and despite the fact that the spatial molecular arrangement in between their positive charges fits perfectly with that in between phosphates in the DNA molecule, suggesting a perfect interaction fit, spermine was shown to bind poorly to DNA, resulting in no DNA protection against nuclease degradation.
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DNA binding by the condensing agent can be improved either by increasing the charge density of the positively charged molecule or by introducing hydrophobic contributions. 18, 19 Thus, the attachment of a short lipidic tail to spermine could potentially improve the binding of this molecule to DNA and thereby affect its ability to protect DNA on condensation. Geall and Blagbrough 19 showed the binding affinity between plasmid DNA (pDNA) and oleic and palmitic lipospermines. Yet, to our knowledge, a good characterization of these conjugates for delivery purposes is still missing. Oleic and palmitic lipospermines are two quite similar derivatives, and a good characterization of spermine conjugates with a more varied hydrocarbon chain should provide larger differences in properties that could be balanced or tuned for delivery purposes. Moreover, there is frequently a lack of correlation with regard to the in vitro characterization properties of delivery vectors and their in vivo expression efficiency.
Therefore, in this study, we introduce a series of six amphiphilic molecules-fatty acid-spermine conjugates (lipospermines, Figure 1 ). Endogenous or naturally occurring lipids were chosen because no major toxicity or inflammation was expected to result from such formulations or from their potential degradation products. Carbon chains of different lengths (between 4 and 18 carbons) and with different saturation levels (between 0 and 3) were attached to spermine. Herein, we describe self-assembling lipospermine/DNA particles and introduce them for gene therapy purposes. The characterization of DNA nanocomplexes included physicochemical and morphological studies. Our results show that, depending on the (+/À) (ammonium to phosphate) ratio, all compounds induce DNA condensation and these nanoparticles can reach an average diameter ranging from 40 to 200 nm. Among the different lipospermines that were analyzed for their in vitro properties, the results suggested decanoyl-and butanoylspermine as the most suitable candidates to be evaluated as in vivo gene delivery vectors. Such DNA particles protected DNA from DNase I degradation and resulted in the most homogenous and stable population of particles. Most importantly, these studies allowed for the selection of the most promising conjugate. Compared with pDNA, butanoylspermine significantly increased gene expression, both in the muscle and dermis, inducing a higher in vivo gene expression by approximately 10-fold.
Results
Toxicity of fatty acid-spermine conjugates increases with the length of the lipidic part Fatty acid-spermine conjugates ( Figure 1 ) were synthesized by reacting the partially protonated polyamine with an acid chloride or a fatty acid activated by isobutylchloroformate. This is a new simplified procedure compared with that previously used for oleyl and palmitoyl derivatives. 19, 20 Given that most of the studied lipospermines are new, or have not been analyzed for the purpose of in vivo gene delivery, we found it relevant to first evaluate their cytotoxic properties. The toxicological evaluation of lipospermines and lipospermine/DNA complexes was assessed using an in vitro cytotoxicity assay on the basis of the activity of mitochondrial dehydrogenases. Cell proliferation is directly correlated to the amount of formazan dye formed, resulting from Figure 1 Fatty acid conjugates used in this study.
Fatty acid-spermine conjugates as DNA carriers JR Viola et al the cleavage of tetrazolium salts using cellular enzymes. A visual inspection of the cells correlated well with the absorbance reading. As expected, toxicity was shown to be concentration dependent and related to the length and degree of saturation of the fatty acid in this class of molecules ( Figure 2 ). In general, toxicity resulting from butanoyl-(4 carbons), decanoyl-(10 carbons), linolyl-(18 carbons, 2C ¼ C) and linolenoylspermines (18 carbons, 3C ¼ C) was low or nonexistent. For the last two compounds, the cells tolerated concentrations up to 80 mM with a low occurrence of cell death (Figure 2a ). In contrast, oleylspermine (containing 18 carbons and one C ¼ C bond) and palmitoylspermine (16 carbons) showed toxicity at concentrations above 10-20 mM (Figure 2a) . For several of the tested compounds, formulation with pDNA resulted in a higher cytotoxicity when compared with that of lipospermines alone (Figure 2b ). When formulated, oleyl-, palmitoyl-, decanoyl-and linolylspermines showed toxicity at a lower concentration than without pDNA. However, oleyl-and palmitoylspermine remained the most toxic compounds. The cytotoxicity of the different fatty acid-spermine conjugates followed the same tendency in a different cell line-baby hamster kidney (see Supplementary data, Supplementary Figure  S1 ). From in vitro assays, it seemed that most of the new conjugates were worth exploring in an in vivo setting.
Interaction of DNA with lipospermines is influenced by the length of the fatty acid chain
We next studied the ability of fatty acid-spermine conjugates to bind to DNA using a gel retardation assay. DNA complexes were formulated at different charge ratios (NH 3 + /PO 4 À ) and were analyzed using agarose gel electrophoresis. An interaction between conjugates and pDNA is seen here as a retardation of the pDNA migration. This retardation is typical for the formation of larger particles as compared with pDNA alone. All lipospermine conjugates were able to interfere with DNA migration in agarose gel, confirming an interaction between them and nucleic acid (Figure 3) . DNA retardation decreased with decreasing length of the lipid tail. This effect became more evident as the concentration of lipospermine molecules increased. As a consequence, neutralization of DNA charge and the formation of heavier DNA particles occurred, decreasing the DNA mobility in the gel until it eventually became retained in the wells. At very high lipospermine concentrations, due to a high condensation state, DNA is no longer available for intercalation by ethidium bromide and was thus not detected in the gel (that is, lanes 5-8 in Figure 3c ). The DNase I protection assay shows that linolenoyl-, linolyland palmitoylspermines (containing 18 and 16 carbons) are able to protect DNA when present in relatively low concentrations (corresponding to 0.3:1 (+/À) ratio) compared with decanoyl-and butanoylspermines, in which at least double concentration is needed to observe a similar DNA protection ( Figure 4 ). Nevertheless, all lipid conjugates were able to protect DNA from degradation, depending on their concentration.
Different saturation levels are shown to influence DNA formulation. 21 Comparing all the unsaturated derivatives, DNA retardation is observed at lower concentrations with complexes formulated with linolylspermine. The DNase I protection assay, on the other hand, is not very conclusive, as bands do not seem to follow any trend. Particularly intriguing and inconclusive is the lack of stronger bands at higher ratios. This fact is likely to be an artifact, owing to the inability of DNA complexes to dissociate (see Supplementary data, Supplementary Figure S2 ), a phenomenon reported earlier. 22 It is also likely that the pDNA purification step (through a column) used in this assay contributed to loss of material. Thus, it is very possible that this procedure impacted on the pDNA band intensity found in the agarose gel in the DNase I protection assay. Interestingly, after the initial studies, we found that repeated handling and exposure to air of linolyl and linolenoylspermine conjugates caused oxidation of these derivatives. Although this does not necessarily disqualify them from use, we chose to exclude these compounds from further characterization for now.
The population of DNA nanocomplexes formed by shorter spermine conjugates shows a narrower size distribution and a smaller average diameter To better characterize the complex formed between lipospermine and pDNA, different lipospermine/DNA preparations were analyzed using dynamic light scattering (DLS). Initially, 0.6:1, 1:1 and 2:1 (+/À) charge ratios were chosen, because we found it to be of particular interest to characterize DNA complexes that were expected to differ significantly in the theoretical total net charge. In addition, if possible, we intended to establish a correlation between these theoretical conditions and the resulting particles. In all clear and transparent preparations, intensity values resulting from Fatty acid-spermine conjugates as DNA carriers JR Viola et al light scattered by particles with diameters larger than 1 mm were neglected, as this light scatter most probably results from dust particles. 18, 23 Most of the formulations presented a relatively broad population distribution, except for decanoylspermine/DNA 1:1 ( Figure 5 ). An increase in the concentration of butanoylspermine in the formulation of DNA complexes resulted in the formation of more stable colloidal solutions, as evidenced by a decrease in the average particle diameter, together with an increase in light intensity ( Figure 5 ). No comparable tendency or particular trend could be observed in the DNA preparations with oleyl-and palmitoylspermine, and both resulted in formulations with a high heterogeneity and polidispersity index. However, unlike oleylspermine, palmitoylspermine/DNA formulated at a 2:1 charge ratio resulted in a turbid solution, composed of large aggregates (41 mm). Interestingly, the quality of decanoylspermine preparations varied significantly within a narrow concentration window. At the 0.6:1 ratio, the population distribution was broad, with an average diameter of approximately 200 nm, whereas decanoylspermine/DNA formulated at a 1:1 ratio resulted in a clearly improved homogeneity and the population distribution with the smallest average diameter (80 nm) and with the highest stability over time. An increase up to the concentration present at 2:1 (+/À) ratio, however, induced colloidal instability, resulting in the precipitation of particles (data not shown). By comparing all four fatty acid conjugates/DNA formulations, at charge ratios of 0.6:1 and 1:1, it is possible to see that the populations with a lower average size are those formed by conjugates with shorter fatty acids. The behavior of butanoyl-and decanoylspermine formulations could be because of the fact that the relatively short hydrocarbon chains result in particle-particle interactions that are weaker. Thus, initially formed DNA complexes would be less prone to aggregate into larger particles through hydrophobic interactions.
Apart from size, morphology is also an interesting property for a drug carrier system and is likely to influence the efficiency of drug uptake. To better characterize this type of nanoparticles, morphological studies of DNA complexes resulting from condensation induced by butanoyl-and decanoylspermines were carried out, either by negative staining or by cryoelectron microscopy (cryo-EM) ( Figure 6 ). The choice of shorter fatty acid derivatives is based on their lower cytotoxicity and on DLS studies, which showed that those formulations were the most homogenous and composed of particles with the lowest average diameter. Figure 3 Gel electrophoresis assay. DNA complexes were formulated at different charge ratios in 5.45% mannitol and analyzed using agarose gel for DNA mobility. Fatty acid-spermine conjugates as DNA carriers JR Viola et al
The average diameter of particles, as shown by the microscopic techniques used here, was in general smaller than that measured by DLS. This has been described before in atomic force microscopy studies, and some explanations have been suggested. Among them is the change in the three-dimensional configuration of the Fatty acid-spermine conjugates as DNA carriers JR Viola et al sample because of interaction with a solid phase, imaging in a dried state or, in the case of cryoEM, the thickness of the vitrified ice layer with embedded sample. [24] [25] [26] The imaging of DNA complexes studied here was not possible using atomic force microscopy, as it resulted in a complete aggregation of the samples tested (data not shown). Alle et al. 27 have reported a similar phenomenon, and depending on the order of addition of the DNA and condensing agent (protamine, in this case) to the mica surface, the shape and size of the resulting particles vary. For decanoylspermine/DNA complexes formulated at 1:1 ratio, cryo-EM revealed the formation of relatively small particles, with a diameter of roughly 40 nm (Figure 6a) , which, by aggregation, formed larger particles (Figure 6b ). Electron microscopy of butanoylspermine/DNA nanocomplexes formed at the charge ratio (+/À) of 2:1 did not show the formation of well-defined particles (Figure 6c ). At the charge ratio of 1:1, the average diameter seen is extremely small, of approximately 15-20 nm ( Figure  6d ). The discrepancy with DLS measurements (average diameter of 200 nm) is quite substantial and we cannot exclude that the negative staining procedure used to visualize these complexes could cause a collapse of initially formed larger particles. In such a case, these structures most likely consist of pure core particles, whereas pDNA partially exists in a free and unbound form in the surrounding medium.
Butanoylspermine formulations result in a significantly increased gene expression on in vivo gene delivery
To address and characterize the in vivo gene expression of lipospermine/DNA complexes, we injected DNA nanocondensates locally in the M. tibialis anterior and in the dermis of mice. Gene expression was observed for 22 days by imaging the action of the luciferase. Different lipospermine/pDNA formulations to be used in this assay were ranked by parameters, such as their low or no detectable cytotoxicity, as well as the homogeneity and stability of the DNA formulation. Therefore, butanoyland decanoylspermine were chosen as pDNA carriers. For initial screening, all three ratios (0.6:1, 1:1 and 2:1) were considered and their ensuing gene expression was observed for 8 days (data not shown). The most promising formulations were thereafter chosen and further analyzed and are reported here. Gene expression followed consistent patterns in both muscle and dermis, although it was more persistent in the muscle (Figure 7 , compare a with b). Butanoylspermine was formulated with pDNA at two different charge ratios, both resulting in a significant increase in gene expression compared with naked pDNA, depending on the targeted organ (Figures 7a and b) . Although DNA complexed with butanoylspermine at the ratio of 0.6:1 seemed to be more suitable for gene delivery into the muscle (Figure 7a ), butanoylspermine/DNA at the ratio of 1:1 significantly increased gene expression in skin (Figures 7a and b ). The DNA particles formed by decanoylspermine at the ratio of 1:1 were only able to induce a higher gene expression than the naked plasmid in six out of eight observation points. Despite the occurrence of an increase, this was not statistically significant (data not shown). With regard to the possible toxicity of the used dosage, histological analyses of muscles (injected with decanoylspermine/DNA nanoparticles) were conducted. In general, if observed at all, pathological changes were considered as mild and no severe pathology was observed in any of the muscle sections (data not shown). No difference could be seen between the muscles injected with the buffer solution and treated muscles, thereby suggesting that the small changes that were seen could be due to the injection itself. Thus, this newly developed system emerges as a promising, safe tool for in vivo gene therapy.
Discussion
Relatively few reports correlate in vitro studies of new compounds for gene delivery with in vivo gene expression data. In this study, we developed a series of fatty acid-spermine conjugates and showed that one of the selected derivatives enhances in vivo gene delivery. Furthermore, we analyzed the in vitro properties of formulated DNA containing particles, and in vivo transfection efficiency. Polyamines have been extensively used for the development of nonviral vectors and this includes studies in which lipospermines typically either contain double or have longer hydrocarbon chains. 18, 21, [28] [29] [30] [31] It has previously been suggested that DNA-binding affinity is a function of both charge and hydrophobicity. 19, 32 However, to what degree this affinity is beneficial for gene delivery is not clear. Some degree of affinity is, certainly, a prerequisite, but it is likely that this has to be balanced towards other properties of the delivery agents and the particles formed on their interaction with DNA.
Here, we tried to evaluate this balance by conducting a comparative study with well-defined and well-characterized lipospermines that differ in the length and saturation of the alkyl chain. We showed that an increase in the length of the hydrocarbon chain resulted in an enhanced gel retardation of DNA, which could indicate higher affinity. However, this is more complex, as the newly formed particles will become larger as the molecular weight of spermine conjugates increases. Results from the DNase I protection assay suggest that the protection of DNA, at equal concentrations, was more prominent with lipospermines having longer hydrocarbon chains and that the degree of saturation affects these properties. In fact, Abbasi et al. 22 see a similar trend in the studies that they conducted with lipid-substituted poly-L-lysine , in which they claim that DNA complex stability increases with the ratio of -CH 2 -groups per poly-L-lysine molecule. One can also speculate about the contribution of hydrophobic interactions to the formulation of DNA nanoparticles on the basis of z-potential studies (see Supplementary Figure S2) . Regardless of the fact that all lipospermine conjugates have the same formal charge (+3), characterization of the z-potential of pDNA complexes showed a fairly large range of potentials for the different nanocomplexes formulated at the same (+/À) charge ratio. The variation found could definitely be attributed to the differences in the carbon chain for butanoyl-and decanoylspermines, with the longer chain giving a more negative potential. Although this trend holds for oleyl and palmitoyl derivatives, it is not excluded that this particular effect is also a consequence of the size of the resulting particles, as these were larger than those formed by butanoyl-and decanoylspermine.
An increase in the length of the hydrocarbon chain was accompanied by an increase in toxicity. This is not unexpected, because a longer aliphatic chain grants the molecules more detergent-like properties and could, thus, increase cell membrane disruption and induce subsequent cell death. On the other hand, inclusion of lipid moieties in the gene carrier could be advantageous for facilitating cell entry. Therefore, a balance between uptake properties and toxicity must be found. In light of the toxicity and DLS studies, we suggest the existence of an optimal length of lipidic moiety among the studied lipospermines that generates the most stable and efficient DNA formulation for the proposed purpose of in vivo gene delivery. A balance between hydrophobic and hydrophilic contribution has been shown to be critical for the functioning of many amphiphilic compounds and as a determining parameter for their transfection efficiency, for example, for the pluronics block copolymers. 33 In this study, we establish a parallel between the importance of this equilibrium and that of the symmetry between the contributions to DNA binding by the two different components of lipospermines. Thus, interaction of butanoylspermine with pDNA is close to a pure cationic interaction. This can be seen in the x-potential of butanoylspermine, which presents values close to neutralization with no significant changes within the range of studied concentrations (see Supplementary Figure S3 ). Also, the behavior expressed by butanoylspermine/DNA nanoparticles in DLS studies is typical of DNA complexes formed by cationic peptides, that is, the improvement in the quality of DNA formulation within a short range of charge ratios tested (from 0.6 to 2:1), as a consequence of the increase in concentration.
Although not clearly verified, a more sizable lipidic portion could potentially increase DNA-binding affinity, and it certainly should increase hydrophobic interaction between initially formed DNA nanocomplexes. Decanoylspermine-derived particles showed a concentrationdependent behavior, suggesting a more balanced contribution from both charged and hydrophobic components toward the properties of nanoparticles. The concentration range used in this study is very narrow (between 20 and 60 mM). Therefore, the concentration window to tune what could be the most optimal DNA nanoparticle formulation that ensues from this series is equally narrow. Interestingly, this fine-tuning also means that the concentrations that are required are low. Thus, this avoids possible toxicity hurdles when used in vivo. In fact, butanoyl-and decanoylspermine were among the conjugates that showed the lowest in vitro cytotoxicity. More importantly, the doses used in vivo did not induce any histological changes per se, underlining the safety of this system and supporting its further development and use in gene therapy. However, considering the nonsignificant relative increase in gene expression of decanoylspermine/DNA nanoparticles, the study of fatty acid Morphological studies showed that DNA nanoparticles resulting from the interaction between decanoyl-and butanoylspermines form a relatively homogenous population with an average diameter ranging approximately from 40 to 200 nm. Previous studies with a chemically different set of spermine derivatives used for DNA condensation have shown the formation of complexes, but not as well defined or with as regular a shape as some of the DNA particles shown in this investigation, particularly with decanoylspermine/DNA. 18, 34 Influence of imaging techniques on morphological characterization of DNA complexes does not seem to be uncommon and cryo-EM emerges as that which may interfere the least. [24] [25] [26] [27] 35 The morphology of these lipospermines is likely to influence their in vivo transfection efficiency, but the correlation is not clear. Moreover, the conditions in which the microscopic techniques were conducted are not physiological. Nevertheless, from the electron micrographs, the pDNA complexes emerge as spherical nanoparticles. It is not probable that these particles correspond to micelles, as it is unlikely that butanoyl-and decanoylspermine can form micelles. Figure 6b suggests the existence of DNA molecules on the surface of these particles. This could, then, possibly explain the aggregation phenomenon: the formation of larger particles as a result of common DNA molecules that interact with the surface of several individual nanoparticles. The structure of lipospermines/DNA nanoparticles is very much dependent on the nature of the fatty acid. Hence, the morphologies herein described do not, necessarily, apply to DNA complexes formed by other lipospermines.
One should emphasize that few delivery systems have been successful in vivo without the use or introduction of a polymer, such as poly-ethylene-glycol or others that suit the same purpose of steric hindrance. [36] [37] [38] The most successful cases occur after intranasal or intratracheal administration, when targeting airway epithelial cells. 3, 5, 9, 39 Tissues containing nondividing cells (as in muscle) or slow mitotic cells (as in the liver) are very attractive targets because pDNA can remain for a long time inside the cells. 40 In relation to the relatively fast kinetics seen here, we do not exclude the possibility that the decrease in expression after 5-7 days may be indicative of toxicity. However, if this is the case, this toxicity should be associated with pDNA, or with its genomic information-such as the exogenous reporter protein-as pDNA alone results in a similar expression profile to that of the formulations, with a parallel decrease. Either way, this 'early decrease' in expression has been previously reported. Chang et al., although targeting M. tibialis anterior in rat, showed a similar decrease between days 5 and 10, whereas Brooks et al. 41 noticed the decrease in mouse M. tibialis anterior after day. 7, 39 Furthermore, Brooks et al. saw a dose-dependent silencing of the expression of the transgene: the higher the initial gene expression the quicker it was silenced. 41 In the study by Chang et al., 38 pDNA was formulated with the block copolymer, PEG-PLGA-PEG.The resulting pDNA complexes induced a significant increase in luciferase expression by threefold, as compared with naked DNA. On the contrary, pDNA complexed with these short lipospermines increased luciferase activity by a factor of 10 over that of naked pDNA. These results are comparable with some of the research carried out with pluronics block copolymers, which have been, and continue to be, extensively explored. 34, 42, 43 Similar to these, as well as to other vehicles, in vitro transfection activity of lipospermines was poor (data not shown). 38, 42 Delivery systems that are efficient in the skeletal muscle or skin may be used for the purpose of DNA vaccine development. In addition, in the muscle, they can also be important for the treatment of disorders caused by the lack of an active protein, which has a systemic effect and can be produced in the muscle and thereafter secreted; for example, the Anderson-Fabry disease. Lavigne et al. 44 have designed a chimeric vector to target skeletal muscle. They developed a device combining the nuclear targeting activity of TAT peptide, together with the specific interactions between the multisubunit DNA-binding protein (M 2 S) and their therapeutic plasmid (encoding for a-galatosidase A protein, AGA). With this vector, they increased protein activity up to eightfold as compared with unformulated plasmid. However, the dose of DNA used was twice as much as that used in this study. In view of the fact that pDNA alone has been used for intramuscular gene delivery and has proven to be very efficient, in a therapeutic setup, a 10-fold enhancement of the protein expression, similar to what is seen with butanoylspermine/DNA formulations, could mean a substantially reduced administration dose. 40 Moreover, because these lipospermines are readily varied, a further tweaking of properties can be investigated. Optimizing particle properties through mixing of different lipospermines may also be a possible way of improving these systems. Moreover, by varying the composition and formulation of DNA nanoparticles, it may be possible to favor delivery into different tissues, similar to what was shown here for butanoylspermine/DNA particles formed at the 0.6:1 ratio. Additional ratios may also be explored.
In conclusion, we synthesized a series of fatty acid spermines for potential use in gene delivery. The properties of their complexes with pDNA have been characterized and there is a clear effect from the fatty acid chain on toxicity as well as on the stability, size and homogeneity of DNA nanocomplexes. Furthermore, in this setup, the fatty acid conjugate with the shortest chain (four carbons long) is the most optimal carrier, inducing the formation of noncytotoxic, homogenous and welldefined DNA/lipospermine nanoparticles, capable of efficient gene delivery in vivo. Thus, the results of this study present a novel platform based on fatty acid-spermine conjugates that can be readily tuned further and optimized for gene delivery purposes.
Materials and methods
Synthesis of fatty acid-spermine conjugates Materials. All reagents for synthesis were of commercial grade (Sigma Aldrich and Fluka brands were purchased from Sigma Aldrich, Sweden) and were used as received; solvents were of p.a. grade. Thin layer chromatography analysis was carried out using precoated Silica Gel 60 F 254 (Merck product, purchased from anhydride (1.64 ml, 10.0 mmol) in dichloromethane (100 ml) was added dropwise for 25 min to a solution of spermine (6.07 g, 30.0 mmol) and trifluoroacetic acid (TFA; 6.93 ml, 90.0 mmol) in methanol-dichloromethane (5:1, 600 ml) at 0 1C. The ice bath was removed and stirring continued at ambient temperature overnight. The mixture was concentrated under reduced pressure and partitioned between 1 M NaOH ((aq.), 500 ml) and chloroform (CHCl 3 )-methanol (9:1, 500 ml). The aqueous layer was separated and back extracted twice with CHCl 3 -methanol (9:1, 500 ml). The combined organic extracts were washed with 600 ml 1 M aqueous NaOH (containing 120 g NaCl) and then with 700 ml methanol-1 M NaOH aq. (1:6), containing120 g NaCl. The organic layer was dried with Na 2 SO 4 and concentrated in vacuo, yielding 2.15 g of crude amine. Crystallization as the trihydrochloride salt from methanol yielded 2.08 g (55%) of product. were dissolved in methanol (500 ml) and dichloromethane (100 ml) at 0 1C. Decanoyl chloride (3.11 ml, 15 mmol) in dichloromethane (100 ml) was added dropwise for over 15 min. After an additional hour at 0 1C, the ice bath was removed and stirring was continued for 24 h. The mixture was then concentrated in vacuo and partitioned between NaOH (aq., 1 M, 200 ml) and chloroform (CHCl 3 )-methanol (9:1, 400 ml). The aqueous layer was back extracted with CHCl 3 -methanol (9:1, 100 ml). The combined organic layers were washed with NaOH (aq., 1 M, 200 ml) and again back extracted with CHCl 3 -methanol (9:1, 100 ml). They were then dried with Na 2 SO 4 and evaporated in vacuo, yielding 4.90 g of crude amine. Crystallization from ethanol as the tri-TFA salt (by addition of a slight excess of TFA) yielded 4.81 g (46 %) of product. -palmitoylspermine tritrifluoroacetate salt. Spermine (3.81 g, 18.8 mmol) was dissolved in methanol (222 ml) at 0 1C and trifluoroacetic acid (4.36 ml, 56.6 mmol) was added. Palmitoyl chloride (576 ml, 1.89 mmol) in dichloromethane (49 ml) was added for over 1.5 h. The reaction was left on a melting ice bath, which turned to room temperature overnight. The sample was concentrated and then partitioned between dichloromethane (200 ml) and NaOH (aq., 1 M, 200 ml). The aqueous layer was separated and reextracted with dichloromethane (2 Â 200 ml). The combined organic extracts were dried with Na 2 SO 4 and evaporated in vacuo, yielding 0.91 g of crude amine. Crystallization from CHCl 3 -ethanol as the tri-TFA salt (by addition of a slight excess of TFA) yielded 762 mg (52 %) of product. 09 mmol) and trifluoroacetic acid (TFA, 7.88 ml, 102 mmol) were dissolved in methanol (455 ml) at 0 1C. Oleic acid (3.37 g, 11.93 mmol), activated at 0 1C with isobutyl chloroformate (1.49 ml, 11.36 mmol) and triethylamine (3.15 ml, 22.7 mmol), in dichloromethane (91 ml) was added for 1 h and 10 min. After another hour, the ice bath was removed and stirring was continued at room temperature for 19 h. The solvent was removed under reduced pressure and the mixture was partitioned between dichloromethane (400 ml) and 1 M NaOH (aq., 400 ml). The aqueous layer was separated and reextracted with dichloromethane (2 Â 400 ml). The combined organic layers were washed with NaOH (aq., 0.5 M, 2 Â 500 ml), dried with Na 2 SO 4 and evaporated in vacuo, yielding 4.77 g of crude amine. Crystallization in CHCl 3 -ethanol (1:1) as the tri-TFA salt (by addition of a slight excess of TFA) yielded 5.44 g (59 %) of product. 1 mmol) and TFA (7.88 ml, 102 mmol) were dissolved in methanol (455 ml) at 0 1C. Linoleic acid (3.35 g, 11.93 mmol), activated at 0 1C with isobutyl chloroformate (1.49 ml, 11.36 mmol) and triethylamine (3.15 ml, 22.72 mmol), in dichloromethane (91 ml) was added for 5 min. After an additional 30 min, the ice bath was removed and stirring was continued at room temperature for 7 h. The sample was concentrated and then partitioned between dichloromethane (600 ml) and NaOH (aq., 1 M, 600 ml). The aqueous layer was separated and reextracted with dichloromethane (3 Â 400 ml). The combined organic extracts were washed with a solution of NaOH (aq., 1 M, 500 ml) saturated with Fatty acid-spermine conjugates as DNA carriers JR Viola et al NaCl, which was also back extracted with dichloromethane (600 ml). The combined organic extracts were dried with Na 2 SO 4 , filtered and evaporated in vacuo, yielding 4.97 g of crude amine. Crystallization in CHCl 3 -ethanol (1:1) as the tri-TFA salt (by addition of a slight excess of TFA) yielded 6.81 g (74 %) of product. After an additional hour, the ice bath was removed and stirring was continued at room temperature overnight. The sample was concentrated and then partitioned between dichloromethane (400 ml) and NaOH (aq., 1 M, 400 ml, with ca. 5% NaCl). The aqueous layer was separated and reextracted with dichloromethane (3 Â 200 ml). The combined organic extracts were washed with NaOH (aq., 0.2 M, 2 Â 1000 ml) in which the aqueous layers were back extracted with dichloromethane (2 Â 300 ml Formulation of DNA nanoparticles Materials. Plasmids: A 6.7-kbp DNA plasmid, based on the pEGFPLuc plasmid (Clonetech, BD Bioscience, CA, USA) and modified as described previously, was used. 45 It was isolated from grown DH5-á cells according to the Qiagen kit (Qiagen, Chatsworth, CA, USA) protocol and its concentration was estimated using ultraviolet-visible spectroscopy.
Formulations of DNA nanoparticles were prepared by equivolumetric mixing of DNA at the desired concentration with fatty acid-spermine conjugates at various concentrations corresponding to different charge ratios (NH 3 +/PO4À), ranging from 0.3:1 to 10:1. DNA complexes were prepared in iso-osmotic mannitol solutions (5.45%). DNA complexes were freshly prepared before each assay. When mentioned, the preparation method involved filtration-using a cellulose acetate filter, 0.2 mm pore size (Whatman Ltd, Maidstone, UK)-after mixing DNA with lipid-spermine compounds.
Gel retardation and DNase I protection assay with lipid-spermine/DNA nanoparticles. Condensation of DNA was first characterized using an electrophoretic assay (0.8% agarose, in 40 mM Tris-acetate, 20 mM sodium acetate and 1 mM ethylenediaminetetraacetic acid-Trisacetate-ethylenediaminetetraacetic acid buffer-pH 7.8). DNA nanoparticles were prepared in 5.45% mannitol solution at a DNA concentration of 0.1 mg ml
À1
. DNA complexes were prepared at different charge ratios by varying the concentrations of the fatty acid spermine conjugate. The degree of DNA protection was analyzed using a DNase I protection assay. In brief, DNA complexes were first incubated with 5 U DNase I per mg of DNA (Roche, Germany) for 15 min. The reaction was stopped by the addition of ethylenediaminetetraacetic acid up to 0.05 M, pH 8.0. Trypsin (Invitrogen, Karlsruhe, Germany) was added to a final concentration of 85 mg l À1 and samples were incubated for 1 h at 37 1C. Sodium dodecyl sulfate was then added, up to 0.1% (w v À1 ) concentration, and DNA was further purified using a PCR purification kit (Qiagen) before being subjected to electrophoresis in agarose gel (0.8% agarose, Tris-acetateethylenediaminetetraacetic acid, pH 7.8) containing ethidium bromide.
Dynamic light scattering (DLS) studies. The stability and hydrodynamic mean diameter of the DNA nanoparticles were determined by dynamic light scattering studies using a zetasizer Nano ZS apparatus (Malvern Instruments, UK). Mannitol solution (5.45%) was introduced into the system as a complex solvent and measurements were carried out using a refractive index of 1.338.
Morphological characterization of lipospermine/DNA nanoparticles. The morphological properties of the ensuing DNA complexes were assessed using negative stain and cryo-EM. In brief, 3 ml of freshly prepared lipospermine/DNA complexes was placed on coated electron microscopy grids and negatively stained with 1% uranyl acetate. The grids were checked using Philips CM120 transmission electron microscope (FEI Company, Eindhoven, The Netherlands). For cryo-EM, 2.5 ml of sample solution was placed on Quantifoil R2/4 holey carbon grids that were blotted and plunge frozen into ethane with a Vitrobot (FEI Company, Eindhoven, The Netherlands). Frozen samples were stored under nitrogen and transferred to a JEOL JEM-2100F (JEOL Ltd, Tokyo, Japan) electron microscope using a Gatan 626 cryo-holder. Data were collected under low-dose conditions on Kodak SO-163 electron micrograph films. A nominal magnification of 50 000 was used. The films were digitized with a Zeiss Scai scanner (Oberkochen, Germany).
Toxicological evaluation. Cytotoxicity of the fatty acidspermine compounds was assessed using WST-8 assay (Roche, Germany), according to the protocol provided by the manufacturer. In brief, human hepatic (HepG2) and baby hamster kidney (BHK) cells were seeded at a density of 1 Â 10 5 and 1 Â 10 4 cells per well, respectively, in 96-well plates and maintained in Dulbecco's modified Eagles' medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) 24 h before transfection.
Fatty acid-spermine conjugates as DNA carriers JR Viola et al
The culture medium was replaced with serum-free Dulbecco's modified Eagles' medium, including various concentrations of lipospermine, ranging from 9 to 92 mM (corresponding to concentrations of the DNA condensates with charge ratios from 0.3:1 to 3:1), or DNA complexes formulated as described above. After 3 h incubation at 37 1C, the cell medium was replaced with Dulbecco's modified Eagles' medium supplemented with 10% fetal bovine serum. The cells were further incubated for 21 h. The number of surviving cells was determined using WST-8 assay. Cell proliferation was expressed as the ratio of the A 450 of treated cells to that of untreated cells.
In vivo studies. The animal experiments were approved by the Swedish local board for laboratory animals. Male BALB/c mice aged 10-13 weeks were first anesthetized with isoflurane gas (400 ml air flow and 4% isoflurane) and kept under anesthesia (220 ml air flow and 2.2% isoflurane) during the administration procedure. Fifty microliters containing 5 mg DNA, either of pDNA or pDNA-nanocomplexes, were injected intradermally or intramuscularly. Nine replicates of each formulation were used for both intramuscular and intradermal studies, except for butanoylspermine formulated at a 1:1 ratio, in which the number of samples was seven. Gene expression was assessed using imaging of the reporter gene (firefly luciferase) expression. On days 1, 8, 16 and 22 after injections, mice were anesthetized and injected intraperitoneally with 150 mg per kg (B3 mg per mouse) of D-Luciferin (Xenogen, Alameda, CA, USA). Light signal (CCD) images were obtained using a cooled IVIS CCD camera (Xenogen), and were analyzed using IGOR-PRO Living Image software, which generates a pseudoimage with an adjustable color scale. The maximum photon per second of acquisition per cm 2 pixel per steridian was determined within a region of interest to be the most consistent measure for comparative analysis. In general, acquisition times ranged from 3 to 5 min. The results were plotted as the average photon counts per second over time.
Statistical analysis. All statistical calculations were performed using Statistica 7.1 (Statsoft Inc., Uppsala, Sweden). The main effects of different fatty acidspermine/DNA nanocomplexes on gene expression were analyzed using a two-way analysis of variance, including all treatments and using time as a repeating variable. To achieve normal distribution, the logarithm of raw data was used. If the overall F-ratio for treatment was significant, pairwise Bonferroni-corrected analyses of variance was performed for comparing the different treatments. A Pp0.05 was considered statistically significant.
Conflict of interest
The authors declare no conflict of interest.
